Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)

NCT00431613 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Stopped Due to Poor Accrual

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Docetaxel
DRUG: Gemcitabine
DRUG: Carboplatin
RADIATION: Chemoradiotherapy
DRUG: Docetaxel

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]